Visceral leishmaniasis, which is also known as Kala-Azar, is one of the most severely
neglected tropical diseases recognized by the World Health Organization (WHO). The threat …

The phenomenon of surface plasmon resonance (SPR) through optical sensors was
developed from initial studies involving excitation of surface plasmons on metallic …

Currently, there is no licensed vaccine to protect against human visceral leishmaniasis (VL),
a potentially fatal disease caused by infection with Leishmania parasites. In the current …

Background Visceral leishmaniasis is the most severe form of leishmaniasis. Worldwide,
approximately 20% of zoonotic human visceral leishmaniasis is caused by Leishmania …

Leishmaniases are neglected diseases caused by infection with Leishmania parasites and
there are currently no prophylactic vaccines. In this study, we designed in silico a synthetic …

Re-emergence and geographic expansion of leishmaniasis is accelerating efforts to develop
a safe and effective Leshmania vaccine. Vaccines using Leishmania recombinant antigens …

The serodiagnosis of human tegumentary leishmaniasis (TL) presents some problems, such
as the low level of antileishmanial antibodies found in most of the patients, as well as the …

Visceral leishmaniasis (VL) or kala-azar, a vector-borne protozoan disease, shows
endemicity in larger areas of the tropical, subtropical and the Mediterranean countries. WHO …

Visceral leishmaniasis (VL) is one of the most important tropical diseases worldwide.
Although chemotherapy has been widely used to treat this disease, problems related to the …

Although there has been an extensive research on vaccine development over the last
decade and some vaccines have been commercialized for canine visceral leishmaniasis …